SAB Biotherapeutics (SABS) Revenue (2021 - 2024)
SAB Biotherapeutics (SABS) posted Revenue of $114698.0 for Q4 2024, down 56.41% on a QoQ basis from $263137.0 in Q2 2024, and down 62.4% year-over-year from $305011.0 in Q1 2024.
SAB Biotherapeutics (SABS) Revenue (2021 - 2024) Analysis & Trends
SAB Biotherapeutics' Revenue history runs 4 years deep, the most recent figure standing at $114698.0 for Q4 2024.
- Quarterly Revenue fell 62.4% year-over-year to $114698.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.3 million (down 40.94% YoY) and the FY2024 annual result came in at $1.3 million, down 40.94% from the prior year.
- Revenue was $114698.0 for Q4 2024 at SAB Biotherapeutics, down from $263137.0 in the prior quarter.
- Across five years, Revenue topped out at $18.2 million in Q2 2021 and bottomed at $85518.0 in Q2 2023.
- A 4-year average of $5.9 million and a median of $2.2 million in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue plunged 98.65% — and 2024, when it surged 207.7%.
- SAB Biotherapeutics' Revenue stood at $11.1 million in 2021, then plunged by 80.46% to $2.2 million in 2022, then sank by 85.88% to $305011.0 in 2023, then sank by 62.4% to $114698.0 in 2024.
- Business Quant data shows SABS's Revenue at $114698.0 in Q4 2024, $263137.0 in Q2 2024, and $944575.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 114,698.00 |
| Jun 30, 2024 | 263,137.00 |
| Mar 31, 2024 | 944,575.00 |
| Dec 31, 2023 | 305,011.00 |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 85,518.00 |
| Mar 31, 2023 | 581,101.00 |
| Dec 31, 2022 | 2.16 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 6.35 Mn |
| Mar 31, 2022 | 11.80 Mn |
| Dec 31, 2021 | 11.06 Mn |
| Sep 30, 2021 | 14.68 Mn |
| Jun 30, 2021 | 18.21 Mn |
| Mar 31, 2021 | 16.93 Mn |